Advanced Oncotherapy (AVO)

 

AVO Share PerformanceMore

52 week high65.00 22/02/17
52 week low9.53 19/07/17
52 week change -9.00 (-13.24%)
4 week volume2,048,618 27/01/18
price59.00
price date1519313214
close59.50

Media for (AVO)

Latest NewsMore

Completion of the Subscription Agreement

RNS Number: 0737F Advanced Oncotherapy PLC 16 February 2018 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Completion of the Subscription Agreement Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that in relation to the announcement date...

Result of Meeting

RNS Number: 6752C Advanced Oncotherapy PLC 23 January 2018 23 January 2018 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Result of GM Advanced Oncotherapy plc (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that at the General Meeting held earlier today, all re...

Director Deals - Advanced Oncotherapy PLC (AVO)

Dr Enrico Vanni, Non Executive Director, bought 40,000 shares in the company on the 11th January 2018 at a price of 54.5...

Director dealing

RNS Number: 6753B Advanced Oncotherapy PLC 12 January 2018 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Director Dealing Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that yesterday Dr Enrico Vanni, Non-Executive Director of the Com...

Advanced Oncotherapy LIGHT system on track

Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, said it remained on...

Notice of GM

RNS Number: 3930A Advanced Oncotherapy PLC 28 December 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Notice of General Meeting Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that a circular (the "Circular") convening the Company's...

Technological update

RNS Number: 3926A Advanced Oncotherapy PLC 28 December 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Technological update LIGHT accelerator and Harley Street construction on track and on target Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment,...

Holding(s) in Company

RNS Number: 2377A Advanced Oncotherapy PLC 22 December 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Advanced Oncotherapy Plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voti...

Fundamental DataMore

EPS-17.01
Dividend yield0 %

Latest discussion posts More

  • Gone quiet

    This hasn't moved for a few days. Whats going on? Frog in a tree
    26-Jan-2018
    frog in a tree
  • Great deal

    So there it is Great deal, by the looks of it. Fully financed for the long term, all looking on track. Directors buying more, and a partner to sell to the far east. Not ...
    7-Dec-2017
    fish lips
  • Nice tick-up

    Nice tick up today on smallish volume, hopefully means good news coming.
    4-Dec-2017
    fish lips

Users' HoldingsMore

Users who hold Advanced Oncotherapy also hold..

Codes & Symbols

ISINGB00BD6SX109
SymbolsAVO, LSE:AVO, AVO.L, AVO:LN, LON:AVO, XLON:AVO

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account